CA
NZ
UK
AU
IND
US
Deal announcements have continued through the third quarter and into October. The largest was Banco Santander's (NYSE:SAN) agreement of February 3 to acquire Webster Financial for about $12.3 billion. The Federal Reserve approved it on August 4, and Webster's shares were delisted on August …
Shares can drop after a beat because the price already reflects expectations, and a result against consensus is only one input. Investors also weigh guidance, margins, cash generation and how far the stock had run before the report. If any of those disappoint, a …
Shares can fall after a beat because guidance, margins, cash flow and what was already priced in matter alongside EPS. Deckers (NYSE:DECK) beat by 28.71% but cut its full-year sales outlook, and Netflix (NASDAQ:NFLX) beat on EPS but cut its 2026 advertising forecast to …
Because Nasdaq's process runs on fixed clocks. A closing bid below $1.00 for 30 consecutive business days produces a deficiency notice, and the company then generally has 180 days to close at or above $1.00 for 10 consecutive business days. A notice from spring …
Three figures frame the debate, and each belongs to a company with its own story. Meta (NASDAQ:META) reported third-quarter free cash flow of negative $2.12 billion on Wednesday, October 21, after capex of $34.91 billion topped operating cash flow of $32.8 billion. Alphabet (NASDAQ:GOOGL) …
Reactions have split on what spending buys. Microsoft (NASDAQ:MSFT) fell about 5% on April 30 after a $190 billion capex plan and closed at $532.95 on October 21, while Meta (NASDAQ:META) reported third-quarter free cash flow of negative $2.12 billion. Alphabet (NASDAQ:GOOGL) rose about …
Four of the market's most closely watched AI spenders report over two days. Microsoft (NASDAQ:MSFT) and Alphabet (NASDAQ:GOOGL) release results after the close on Wednesday, October 28, with Microsoft's call at 2:30 p.m. Pacific and Alphabet's at 4:30 p.m. Eastern.
The week's reporters beat on profit and still met mixed reactions. Netflix (NASDAQ:NFLX) reported on Tuesday, October 20, with earnings of $0.87 per share against $0.82 expected, but shares fell 5.31% to $65.04 on October 21 as its 2026 advertising forecast was cut to …
What Are the Biggest Biotech Catalysts This Week, From Kidney Week Data to FDA Holds and Medicare Rates?
It appears to be a recurring pattern in small and mid-sized biotech, and the absence of a headline is not by itself a warning. Shares of companies with no sales are priced on expectations for trials and regulators, so they can move when holders …
Please wait processing your request...